Decision aids for breast cancer chemoprevention

Decision aids for breast cancer surgery: a randomised controlled trial.

Selection criteria for breast cancer chemoprevention subjects.

Early phase chemoprevention trials differ from standard therapeutic clinical trials because asymptomatic, healthy people are treated with a potentially toxic intervention for a prolonged period of time. Current subject selection protocols have relied upon epidemiological methods to identify high-risk individuals. Most available data provide risk estimates for various individual risk factors, bu...

Women's interest in chemoprevention for breast cancer.

BACKGROUND Chemoprevention is the use of pharmacologic or natural agents to inhibit the development of cancer. Tamoxifen citrate is the only approved chemopreventive agent for breast cancer. We sought to determine whether women are interested in taking a drug to prevent breast cancer and to assess the relationship between objective and subjective breast cancer risk and interest in chemopreventi...

Natural Products for Chemoprevention of Breast Cancer

Breast cancer is the primary cause of cancer death in women. Although current therapies have shown some promise against breast cancer, there is still no effective cure for the majority of patients in the advanced stages of breast cancer. Development of effective agents to slow, reduce, or reverse the incidence of breast cancer in high-risk women is necessary. Chemoprevention of breast cancer by...

Chemoprevention for breast cancer: are we ready?

Despite recent advances in the management of breast cancer, there has been no noticeable improvement in the mortality rate. In fact, the reported incidence of breast cancer is rising (7,2). Although early detection through mammography screening may contribute to this increase, the main causes have yet to be delineated (3). Factors that concern many investigators include changes in dietary habit...